VANCOUVER, Nov. 14 /CNW/ - Chemokine Therapeutics Corp. (the "Company")
(TSX:CTI, OTCBB:CHKT), a biotechnology company developing chemokine-based
therapies to treat cancer, blood disorders and vascular diseases, today
announced the financial and operating results of the third quarter ended
September 30, 2006.
